Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) FCF Margin (2023 - 2025)

Onconetix (ONCO) has disclosed FCF Margin for 2 consecutive years, with 372.74% as the latest value for Q4 2024.

  • On a quarterly basis, FCF Margin rose 130870.0% to 372.74% in Q4 2024 year-over-year; TTM through Dec 2024 was 673.27%, a 299932.0% decrease, with the full-year FY2024 number at 1205.41%, up 2444037.0% from a year prior.
  • FCF Margin was 372.74% for Q4 2024 at Onconetix, up from 282.38% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 3689.36% in Q2 2023 to a low of 273278.64% in Q1 2023.